Search research articles
Contact Us
Filters
Showing results (411-420 of 1,833) with videos related to
Page
of 184
Sort By:
Mabs
|
February 26, 2026
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
Rajesh K Mistry, Chendi Nui, Giulia Lambiase, et al.
Mabs
|
March 10, 2026
Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinoma
Danlin Yang, Neha Kamran, Gururaj Shivange, et al.
Mabs
|
June 4, 2025
Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies
Luke S Heuer, Nicolle Sweeney, Manuel Rojas, et al.
Mabs
|
May 25, 2025
Data-driven analyses of human antibody variable domain germlines: pairings, sequences and structural features
Clarissa A Seidler, Vera A Spanke, Jakob Gamper, et al.
Mabs
|
May 4, 2026
Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody
Laura Bracke, Heidi Gytz Olesen, Erwin Pannecoucke, et al.
Mabs
|
March 25, 2026
Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates
Gregory Christianson, Zachary M Howard, Samantha Kenney, et al.
Mabs
|
May 8, 2026
A comprehensive evaluation of the human Tg32 and Tg276 FcRn transgenic mouse and non-human primate models for predicting antibody pharmacokinetics in human
Monika Gajewska, Michael Kiffe, Claudio Calonder, et al.
Mabs
|
May 21, 2026
Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial
Dirk van Lier, Louis Mourisse, Hákon Hollander, et al.
Mabs
|
June 4, 2026
Generation of human sequence antibodies in OmniChicken against the highly conserved mammalian target BDNF using three distinct discovery workflows
Kathryn H Ching, Sinéad Keating, Baisen Zeng, et al.
Mabs
|
June 11, 2026
Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B
Macy Jin, Sunita Hett, Reema Jasuja, et al.
Page
of 184
Search research articles
Search
Showing results (411-420 of 1,833) with videos related to
Sort By:
Page
of 184
Mabs
|
February 26, 2026
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
Rajesh K Mistry, Chendi Nui, Giulia Lambiase, et al.
Mabs
|
March 10, 2026
Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinoma
Danlin Yang, Neha Kamran, Gururaj Shivange, et al.
Mabs
|
June 4, 2025
Higher order receptor clustering due to the IgG3 subclass is necessary for TLR4 signaling and tolerance induction by novel human anti-TLR4 antibodies
Luke S Heuer, Nicolle Sweeney, Manuel Rojas, et al.
Mabs
|
May 25, 2025
Data-driven analyses of human antibody variable domain germlines: pairings, sequences and structural features
Clarissa A Seidler, Vera A Spanke, Jakob Gamper, et al.
Mabs
|
May 4, 2026
Structure-function analysis of empasiprubart, a calcium- and pH-dependent clinical phase complement C2 blocking antibody
Laura Bracke, Heidi Gytz Olesen, Erwin Pannecoucke, et al.
Mabs
|
March 25, 2026
Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates
Gregory Christianson, Zachary M Howard, Samantha Kenney, et al.
Mabs
|
May 8, 2026
A comprehensive evaluation of the human Tg32 and Tg276 FcRn transgenic mouse and non-human primate models for predicting antibody pharmacokinetics in human
Monika Gajewska, Michael Kiffe, Claudio Calonder, et al.
Mabs
|
May 21, 2026
Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial
Dirk van Lier, Louis Mourisse, Hákon Hollander, et al.
Mabs
|
June 4, 2026
Generation of human sequence antibodies in OmniChicken against the highly conserved mammalian target BDNF using three distinct discovery workflows
Kathryn H Ching, Sinéad Keating, Baisen Zeng, et al.
Mabs
|
June 11, 2026
Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B
Macy Jin, Sunita Hett, Reema Jasuja, et al.
Page
of 184